Share Name Share Symbol Market Type Share ISIN Share Description
Provexis Plc LSE:PXS London Ordinary Share GB00B0923P27 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.735p 0.70p 0.77p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Producers 0.1 -0.5 -0.0 - 12.79

Provexis (PXS) Latest News

More Provexis News
Provexis Takeover Rumours

Provexis (PXS) Share Charts

1 Year Provexis Chart

1 Year Provexis Chart

1 Month Provexis Chart

1 Month Provexis Chart

Intraday Provexis Chart

Intraday Provexis Chart

Provexis (PXS) Discussions and Chat

Provexis Forums and Chat

Date Time Title Posts
16/1/201720:36Provexis: a new beginning983.00
27/11/201611:05PROVEXIS PLC (Sirco)40,145.00
27/4/201311:43Blatherskites, trolls, bashers & duplicitous 'investors'631.00
04/9/201216:24PXS herd mentality, medicine, moneymen and manipulation3,710.00
20/6/201200:07The Pixies 'Time To Grow Your Tomatoes' Thread54.00

Add a New Thread

Provexis (PXS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16/01/2017 16:28:490.7510,00075.25O
16/01/2017 15:54:450.721,000,0007,175.00O
16/01/2017 14:59:550.751,000,0007,451.00O
16/01/2017 14:58:500.742,000,00014,840.20O
16/01/2017 14:54:550.75500,0003,750.00AT
View all Provexis trades in real-time

Provexis (PXS) Top Chat Posts

DateSubject
17/1/2017
08:20
Provexis Daily Update: Provexis Plc is listed in the Food Producers sector of the London Stock Exchange with ticker PXS. The last closing price for Provexis was 0.74p.
Provexis Plc has a 4 week average price of 0.85p and a 12 week average price of 0.73p.
The 1 year high share price is 1.25p while the 1 year low share price is currently 0p.
There are currently 1,740,401,507 shares in issue and the average daily traded volume is 4,563,247 shares. The market capitalisation of Provexis Plc is £12,791,951.08.
21/12/2016
01:34
wheelds: Looks like the next RNS will bring a share price rise:- (8 out of 10 Up) 07:00 20-Dec-2016 PXS Fruitflow and Blood Pressure - second stage update RNS +18.62% Up 07:00 23-Nov-2016 PXSStudy publication - comparison with aspirin RNS +87.90% Up 09:46 18-Nov-2016 PXS New Collaboration for Fruitflow RNS +50.00% Up 15:33 30-Sep-2016 PXS Result of AGM RNS +5.85% Up 17:08 15-Sep-2016 PXS Director/PDMR Shareholding RNS -1.46% Down 07:00 07-Sep-2016 PXS Preliminary Results RNS -6.49% Down 10:23 02-Sep-2016 PXS Holding(s) in Company RNS +9.27% Up 07:00 02-Aug-2016 PXS Results of Placing RNS +2.44% Up 07:00 12-Jul-2016 PXS Study Publication RNS +5.39% Up 07:05 29-Jun-2016 PXS Funding Update RNS +8.61% Up 07:00 29-Jun-2016 PXS Product Launch RNS +8.61% Up -------------------------------------------------------------------------------------------------------------------------------------------------------
13/12/2016
01:51
wheelds: With all this media coverage and the China collaboration deal, and the fact that governments around the world, including China and America are getting concerned about the cost of caring for patience suffering from heart problems; and with our interims due this December 2016, lets hope all is good for share price to reflect the potential of our Fruitflow healthy blood circulation product in the global market world of today.
27/11/2016
21:27
underhill2: A lot of nonsense posts posts this weekend as expected.As a long term investment speculative investment I'm more than happy to hold. The BP results will be very important and will have a major affect on the share price either positive or negative.
25/11/2016
14:01
underhill2: Would not surprise me if we are a takeover here within the next couple of years. The potential as a safe alternative to aspirin is enormous.I would not be suprised to see the share price at a much higher level in a years time. Under 1p will soon be a distant memory. This is all in my opinion of course. As I said yesterday it's a speculative investment but the rewards could be fantastic.
24/11/2016
16:37
underhill2: In my portfolio this is a long term Investment. The potential Market in China is enormous. Yes the share price will be subject to large daily swings. It's a speculative investment and not without risk. Hopefully this will come good
24/11/2016
03:29
wheelds: From the news:- Promoting Fruitflow plus omega 3:- "scientists at Provexis have extracted these ingredients and combined them with omega-3 in capsule that has been classified as a food. Experts said for at least six weeks, the supplement will work to promote normal blood flow and normal heart function." All looking good.IMHO Last time collaboration with Coca Cola the share price rose to 15p/20p before Coca Cola pulled out and share price fell to ridiculously low levels like 0.25p but now back on track with Chinese collaboration deal and latest news, and I can not see the Chinese pulling out or DSM pulling out with their Omega 3 now combined with our Fruitflow. .
23/11/2016
16:31
wheelds: News out today on Aspirin verus Fruitflow tests:- That's on top of the China Collaboration deal; so all looking good and being reported in the press. So all good for share price rise: And you never know, last time on news of Collaboration between Coca Cola on top of good news like this, shares price rose to 15p/20p before Coca Cola pulled out and share price fell; But this time I can't see the Chinese pulling out and the medical profession ignoring the aspirin - Fruitflow results this time around. "The study findings are significant and serve to demonstrate the potential effectiveness of Fruitflow® as a dietary supplement with a significant effect on blood flow, suitable for daily use in primary prevention of CVD, and with no adverse side effects." "The World Health Organization reports that more people die annually from CVDs than from any other cause¹ and the global market for cardiovascular disease, to include dietary supplements, is estimated to be in excess of $10 billion per year." "The US FDA states that after carefully examining scientific data from major studies, it has concluded 'the data do not support the use of aspirin as a preventive medication by people who have not had a heart attack, stroke or cardiovascular problems, a use that is called 'primary prevention.' In such people, the benefit has not been established but risks - such as dangerous bleeding into the brain or stomach - are still present.' ²
18/11/2016
16:25
wheelds: Same as last time; when good news of partnership with Coca Cola and the share price rose and fell and rose and fell and over the year rose from 0.6p to around 15p-22p before Coca Cola pulled out after the end of the year. So, in my opinion the share price will rise and fall but over the year will be much higher then today; - Last time when it got to 5p it then dropped to 3p and the rose again to 8p etc. etc. We have a great product with Fruitflow and as the good Chinese news spreads around the globe you will get other large companies in America etc. seeing this as a challenge to their health products and will try to also get a trade deal/partnership deal going with DSM and Provexis for our Fruitflow. IMHO
18/11/2016
15:23
wheelds: "Developer of the Fruitflow heart-health functional food product, Provexis, announced on Friday that the company's alliance partner for Fruitflow, DSM Nutritional Products, has entered into a strategic collaboration agreement for Fruitflow with BY-HEALTH Co, a substantial listed Chinese dietary supplement business." And the share price rises today, all good information.IMHO
15/8/2016
00:00
wheelds: We have had a terrible last 5 years but all being well we are hopefully now on the mend which will be highlighted come this September..IMHO 07:00 02-Aug-2016 PXS Results of Placing RNS +2.44% Up 07:00 12-Jul-2016 PXS Study Publication RNS +5.39% Up 07:05 29-Jun-2016 PXS Funding Update RNS +8.61% Up 07:00 29-Jun-2016 PXS Product Launch RNS +8.61% Up July low share price 0.26p today 0.36p = 40% rise in one month. Preliminary Results September 2016 Annual General Meeting 30 September 2016
Provexis share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170117 09:04:09